Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Controlled Trial Comparing Tissue Plasminogen Activator With Dual Antiplatelet Therapy for Patients With Hyperacute Single Perforating Artery Infarction

NCT07111559 is registered in ClinicalTrials.gov with Nippon Medical School as lead sponsor.

NCT NCT07111559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07111559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Controlled Trial Comparing Tissue Plasminogen Activator With Dual Antiplatelet Therapy for Patients With Hyperacute Single Perforating Artery Infarction
Lead sponsor
Nippon Medical School
Phase
Phase 4
Overall status
Recruiting
Start date
August 1, 2025
Completion date
March 31, 2029
Enrollment
500 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, lacunar stroke, stroke